Results 281 to 290 of about 81,723 (303)

Trends in kinase drug discovery: targets, indications and inhibitor design

Nature Reviews Drug Discovery, 2021
Misty M Attwood, Stefan Knapp, Aleksandr Sokolov   +2 more
exaly  

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active psoriatic arthritis (EQUATOR): results from a randomised, placebo-controlled, phase 2 trial

Lancet, The, 2018
Philip J Mease, Laura C Coates Mb Chb, Mykola A Stanislavchuk   +2 more
exaly  

Efficacy and safety of filgotinib, a selective Janus kinase 1 inhibitor, in patients with active ankylosing spondylitis (TORTUGA): results from a randomised, placebo-controlled, phase 2 trial

Lancet, The, 2018
Désirée M Van Der Heijde, Xenofon Baraliakos, Lianne S Gensler   +2 more
exaly  

Janus kinase inhibitors for the treatment of myeloproliferative neoplasias and beyond

Nature Reviews Drug Discovery, 2011
Hagop M Kantarjian, Jorge Cortes, Srdan Verstovsek,,, of Medicine   +2 more
exaly  

Phosphodiesterase-4 and Janus Kinase Inhibitors

2021
Gillian Weston, Bruce Strober
openaire   +1 more source

Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis

New England Journal of Medicine, 2012
Subrata Ghosh, Julian Panes
exaly  

Oral spleen tyrosine kinase/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: Results of a randomized phase 2 study

Journal of the American Academy of Dermatology, 2023
exaly  

Janus Kinase Inhibitors

2016
openaire   +1 more source

AN OVERVIEW OF JANUS KINASE INHIBITORS

Rheumatology Quarterly, 2023
openaire   +1 more source

Effect of Janus Kinase Inhibitor Treatment on Anterior Uveitis and Associated Macular Edema in an Adult Patient with Juvenile Idiopathic Arthritis

Ocular Immunology and Inflammation, 2019
Arnd Heiligenhaus, Carsten Heinz
exaly